Citations (169)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Abhi Das, Jeet Chakraborty, Soching Luikham, Sayanika Banerjee, Jhimli Bhattacharya & Sanjay Dutta. (2023) Targeting aloe active compounds to c-KIT promoter G-quadruplex and comparative study of their anti proliferative property. Journal of Biomolecular Structure and Dynamics 41:19, pages 9686-9694.
Read now
Read now
Abdelbaset Mohamed Elasbali, Waleed Abu Al-Soud, Elyasa Mustafa Elfaki, Hamad H. Alanazi, Bandar Alharbi, Salem Hussain Alharethi, Khalid Anwer, Taj Mohammad & Md. Imtaiyaz Hassan. (2023) Identification of novel c-Kit inhibitors from natural sources using virtual screening and molecular dynamics simulations. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-13.
Read now
Read now
Zeng Wang, Liyu Jiang, Hao Yan, Zhifei Xu & Peihua Luo. (2021) Adverse events associated with nilotinib in chronic myeloid leukemia: mechanisms and management strategies. Expert Review of Clinical Pharmacology 14:4, pages 445-456.
Read now
Read now
Lin Yu, Qinhuai Lai, Lantu Gou, Jiafu Feng & Jinliang Yang. (2021) Opportunities and obstacles of targeted therapy and immunotherapy in small cell lung cancer. Journal of Drug Targeting 29:1, pages 1-11.
Read now
Read now
Suresh Gopi Kalathil, Katy Wang, Alan Hutson, Renuka Iyer & Yasmin Thanavala. (2020) Tivozanib mediated inhibition of c-Kit/SCF signaling on Tregs and MDSCs and reversal of tumor induced immune suppression correlates with survival of HCC patients. OncoImmunology 9:1.
Read now
Read now
Ellen Weisberg, Martin Sattler, Paul W Manley & James D Griffin. (2018) Spotlight on midostaurin in the treatment of FLT3-mutated acute myeloid leukemia and systemic mastocytosis: design, development, and potential place in therapy. OncoTargets and Therapy 11, pages 175-182.
Read now
Read now
Articles from other publishers (163)
Jiaran Zhang, Huichun Tian, Lili Mao & Lu Si. (2024) Treatment of acral and mucosal melanoma: Current and emerging targeted therapies. Critical Reviews in Oncology/Hematology 193, pages 104221.
Crossref
Crossref
Palak A. Patel, Prakash A. Patel, Samuel D. Moelis, Anna G. Ivenitsky & Colby C. Robinson. 2024. Therapy Resistance in Prostate Cancer. Therapy Resistance in Prostate Cancer
179
211
.
Ramak Ajideh, Hanieh Kamyab & Mohammad Hossein Yazdi. 2024. Encyclopedia of Toxicology. Encyclopedia of Toxicology
915
946
.
Yashasvi Bhat, M. R. Thrishna & Satarupa Banerjee. (2023) Molecular targets and therapeutic strategies for triple-negative breast cancer. Molecular Biology Reports 50:12, pages 10535-10577.
Crossref
Crossref
Satabdi Datta Choudhury, Prateek Kumar & Diptiman Choudhury. (2023) Bioactive nutraceuticals as G4 stabilizers: potential cancer prevention and therapy—a critical review. Naunyn-Schmiedeberg's Archives of Pharmacology.
Crossref
Crossref
Darren Fergal Beirne, Barbara Farkaš, Chiara Donati, Valentina Gandin, Isabel Rozas, Trinidad Velasco-Torrijos & Diego Montagner. (2023)
Novel design of dual-action Pt(
iv
) anticancer pro-drugs based on cisplatin and derivatives of the tyrosine kinase inhibitors imatinib and nilotinib
. Dalton Transactions 52:39, pages 14110-14122.
Crossref
Crossref
Guoqing Fang, Hongjuan Chen, Zhiyun Cheng, Zilong Tang & Yichao Wan. (2023) Azaindole derivatives as potential kinase inhibitors and their SARs elucidation. European Journal of Medicinal Chemistry 258, pages 115621.
Crossref
Crossref
Keshav Taruneshwar Jha, Abhimannu Shome, Chahat & Pooja A Chawla. (2023) Recent advances in nitrogen-containing heterocyclic compounds as receptor tyrosine kinase inhibitors for the treatment of cancer: Biological activity and structural activity relationship. Bioorganic Chemistry 138, pages 106680.
Crossref
Crossref
A. Eggert, J.-A. Mäkelä, M. Nurmio, S. Leskinen, A. Wahlgren, K. Jahnukainen, N. Kotaja & J. Toppari. (2023) P08-07: Imatinib Decreases DNA synthesis, germ cell survival, and stem cell proliferation and differentiation in rodent testis. Toxicology Letters 384, pages S127.
Crossref
Crossref
Alessandro Marchioni, Roberto Tonelli, Anna Valeria Samarelli, Gaia Francesca Cappiello, Alessandro Andreani, Luca Tabbì, Francesco Livrieri, Annamaria Bosi, Ottavia Nori, Francesco Mattioli, Giulia Bruzzi, Daniele Marchioni & Enrico Clini. (2023) Molecular Biology and Therapeutic Targets of Primitive Tracheal Tumors: Focus on Tumors Derived by Salivary Glands and Squamous Cell Carcinoma. International Journal of Molecular Sciences 24:14, pages 11370.
Crossref
Crossref
Yuquan Xiong, Meriem Taleb, Kyohei Misawa, Zhaohua Hou, Srijita Banerjee, Alfredo Amador-Molina, David R. Jones, Navin K. Chintala & Prasad S. Adusumilli. (2023) c-Kit signaling potentiates CAR T cell efficacy in solid tumors by CD28- and IL-2-independent co-stimulation. Nature Cancer.
Crossref
Crossref
Robert C. Monsen. (2023) Higher-order G-quadruplexes in promoters are untapped drug targets. Frontiers in Chemistry 11.
Crossref
Crossref
Rui Su, Chuting Li, Xiuyuan Wang, Zhendong Li, Ziqi Wen, Zhao Yin, Guiping Huang, Yanjun Liu, Juhua Yang, Haiyan Hu, Hong Nie, Keda Zhang & Jia Fei. (2023) PPFIA1-targeting miR-181a mimic and saRNA overcome imatinib resistance in BCR-ABL1-independent chronic myeloid leukemia by suppressing leukemia stem cell regeneration. Molecular Therapy - Nucleic Acids 32, pages 729-742.
Crossref
Crossref
Kenny Zhuoran Wu, Christabella Adine, Aleksandr Mitriashkin, Benjamin Jun Jie Aw, N. Gopalakrishna Iyer & Eliza Li Shan Fong. (2023) Making In Vitro Tumor Models Whole Again. Advanced Healthcare Materials 12:14.
Crossref
Crossref
Sreenivasulu Godesi, Joohan Lee, Hossam Nada, Guofeng Quan, Ahmed Elkamhawy, Yongseok Choi & Kyeong Lee. (2023) Small Molecule c-KIT Inhibitors for the Treatment of Gastrointestinal Stromal Tumors: A Review on Synthesis, Design Strategies, and Structure–Activity Relationship (SAR). International Journal of Molecular Sciences 24:11, pages 9450.
Crossref
Crossref
Vanktesh Kumar, Navjot Kaur, Sanjeev Sahu, Vikas Sharma, Deepak Kumar, Ajit Sharma & Pankaj Wadhwa. (2023) Role of Tyrosine Kinases and their Inhibitors in Cancer Therapy: A
Comprehensive Review. Current Medicinal Chemistry 30:13, pages 1464-1481.
Crossref
Crossref
Aleyamma Alexander, Archana Sumohan Pillai, Sudhaker Raboni Grace, Nallamuthu Ananthi, Haridas Pal, Israel Vijayaraj Muthu Vijayan Enoch & Mhejabeen Sayed. (2023) Play of molecular host: guest assembly on a G-quadruplex binder. Journal of Inclusion Phenomena and Macrocyclic Chemistry 103:3-4, pages 147-159.
Crossref
Crossref
Nasim Ebrahimi, Elmira Fardi, Hajarossadat Ghaderi, Sahar Palizdar, Roya Khorram, Reza Vafadar, Masoud Ghanaatian, Fatemeh Rezaei-Tazangi, Payam Baziyar, Amirhossein Ahmadi, Michael R. Hamblin & Amir Reza Aref. (2023) Receptor tyrosine kinase inhibitors in cancer. Cellular and Molecular Life Sciences 80:4.
Crossref
Crossref
María del Pilar Navarrete-Meneses, Consuelo Salas-Labadía, María del Rocío Juárez-Velázquez, Dafné Moreno-Lorenzana, Fernando Gómez-Chávez, Alberto Olaya-Vargas & Patricia Pérez-Vera. (2023) Exposure to Insecticides Modifies Gene Expression and DNA Methylation in Hematopoietic Tissues In Vitro. International Journal of Molecular Sciences 24:7, pages 6259.
Crossref
Crossref
Maria Teresa Masucci, Maria Letizia Motti, Michele Minopoli, Gioconda Di Carluccio & Maria Vincenza Carriero. (2023) Emerging Targeted Therapeutic Strategies to Overcome Imatinib Resistance of Gastrointestinal Stromal Tumors. International Journal of Molecular Sciences 24:7, pages 6026.
Crossref
Crossref
Fang Cheng, Qiling Xu, Qiang Li, Zheng Cui, Weiming Li & Fang Zeng. (2023) Adverse reactions after treatment with dasatinib in chronic myeloid leukemia: Characteristics, potential mechanisms, and clinical management strategies. Frontiers in Oncology 13.
Crossref
Crossref
Enas Abd-El Hay Taha Tolba & Hanan Zaher Ahmed Amer. (2023) In silico Analysis of Tyrosine Kinases Receptor in Papillary and Medullary Thyroid Cancer Using Sequence-alignment-based Methods. Biotechnology(Faisalabad) 22:1, pages 18-27.
Crossref
Crossref
Valentina B. Stevenson, Shawna Klahn, Tanya LeRoith & William R. Huckle. (2023) Canine melanoma: A review of diagnostics and comparative mechanisms of disease and immunotolerance in the era of the immunotherapies. Frontiers in Veterinary Science 9.
Crossref
Crossref
Alessandra Dimino, Chiara Brando, Laura Algeri, Valerio Gristina, Erika Pedone, Marta Peri, Alessandro Perez, Ida De Luca, Roberta Sciacchitano, Luigi Magrin, Tancredi Didier Bazan Russo, Marco Bono, Nadia Barraco, Silvia Contino, Maria La Mantia, Antonio Galvano, Giuseppe Badalamenti, Antonio Russo, Viviana Bazan & Lorena Incorvaia. (2022) Exploring the Dynamic Crosstalk between the Immune System and Genetics in Gastrointestinal Stromal Tumors. Cancers 15:1, pages 216.
Crossref
Crossref
Yunju Nam, Chan Kim, Junghee Han, SeongShick Ryu, Hanna Cho, Chiman Song, Nam Doo Kim, Namkyoung Kim & Taebo Sim. (2022) Identification of Thiazolo[5,4-b]pyridine Derivatives as c-KIT Inhibitors for Overcoming Imatinib Resistance. Cancers 15:1, pages 143.
Crossref
Crossref
Ala’a S. Shraim, Bayan A. Abdel Majeed, Maysaa’ Adnan Al-Binni & Abdelrahim Hunaiti. (2022) Therapeutic Potential of Aptamer–Protein Interactions. ACS Pharmacology & Translational Science 5:12, pages 1211-1227.
Crossref
Crossref
Hironori Arai, Yosuke Minami, SungGi Chi, Yoshikazu Utsu, Shinichi Masuda & Nobuyuki Aotsuka. (2022) Molecular-Targeted Therapy for Tumor-Agnostic Mutations in Acute Myeloid Leukemia. Biomedicines 10:12, pages 3008.
Crossref
Crossref
Afia Muhammad Akram, Mubashir Hassan, Asma Chaudhary, Sikandar Hayat, Qurban Ali, Taha Hussain, Amjad Zafar & Muhammad Arshad Javed. (2022) Identification and in silico analysis of noval alteration Arg420Gly in KIT proto oncogene among acute myeloid leukemia patients. Scientific Reports 12:1.
Crossref
Crossref
Ion G. Motofei. (2022) Biology of cancer; from cellular and molecular mechanisms to developmental processes and adaptation. Seminars in Cancer Biology 86, pages 600-615.
Crossref
Crossref
Eleonora Nardi, Viola Seravalli, Caterina Serena, Federico Mecacci, Daniela Massi, Bruno Bertaccini, Mariarosaria Di Tommaso & Francesca Castiglione. (2022) A study on the placenta in stillbirth: an evaluation of molecular alterations through next generation sequencing. Placenta 129, pages 7-11.
Crossref
Crossref
Meixu Chen, Xin Chen, Guidong Huang, Yanlin Jiang, Yi Gou & Jungang Deng. (2022) Synthesis, anti-tumour activity, and mechanism of benzoyl hydrazine Schiff base-copper complexes. Journal of Molecular Structure 1268, pages 133730.
Crossref
Crossref
Mohammad Habeeb, Tasneem Abdul Kareem, Kolluru Lakshmi Deepthi, Vidyarani Sujitkumar Khot, You Huay Woon & Sarita Suryabhan Pawar. (2022) Nanomedicine for targeting the lung cancer cells by interpreting the signaling pathways. Journal of Drug Delivery Science and Technology 77, pages 103865.
Crossref
Crossref
Ming Han, Fei Li, Yehan Zhang, Pengfei Dai, Juan He, Yunguang Li, Yiqin Zhu, Junke Zheng, Hai Huang, Fan Bai & Dong Gao. (2022) FOXA2 drives lineage plasticity and KIT pathway activation in neuroendocrine prostate cancer. Cancer Cell 40:11, pages 1306-1323.e8.
Crossref
Crossref
Angélica Sandoval-Pérez, Beth Apsel Winger & Matthew P. Jacobson. (2022) Assessing the Activation of Tyrosine Kinase KIT through Free Energy Calculations. Journal of Chemical Theory and Computation 18:10, pages 6251-6258.
Crossref
Crossref
Darren F. Beirne, Martina Dalla Via, Trinidad Velasco-Torrijos & Diego Montagner. (2022) Metal-Tyrosine Kinase Inhibitors: Targeted metal-drug conjugates. Coordination Chemistry Reviews 469, pages 214655.
Crossref
Crossref
Chan Yang, Yan Gu, Zheng Ge & Chunhua Song. (2022) Targeting EZH2 Promotes Chemosensitivity of BCL-2 Inhibitor through Suppressing PI3K and c-KIT Signaling in Acute Myeloid Leukemia. International Journal of Molecular Sciences 23:19, pages 11393.
Crossref
Crossref
Katerina Kalkusova, Sindija Smite, Elea Darras, Pavla Taborska, Dmitry Stakheev, Luca Vannucci, Jirina Bartunkova & Daniel Smrz. (2022) Mast Cells and Dendritic Cells as Cellular Immune Checkpoints in Immunotherapy of Solid Tumors. International Journal of Molecular Sciences 23:19, pages 11080.
Crossref
Crossref
Markus Kraiger, Tanja Klein-Rodewald, Birgit Rathkolb, Julia Calzada-Wack, Adrián Sanz-Moreno, Helmut Fuchs, Eckhard Wolf, Valérie Gailus-Durner & Martin Hrabě de Angelis. (2022) Monitoring longitudinal disease progression in a novel murine Kit tumor model using high-field MRI. Scientific Reports 12:1.
Crossref
Crossref
Xu Wang, Yi Zhou, Yan Wang, Xiang Wang, Yu Zhang, Yufei Mao, Long Zhang, Ji Qi, Yining Zhang, Feng Lyu, Linbo Gu, Rutong Yu & Xiuping Zhou. (2022) SU4312 Represses Glioma Progression by Inhibiting YAP and Inducing Sensitization to the Effect of Temozolomide. Journal of Clinical Medicine 11:16, pages 4765.
Crossref
Crossref
Diego Alvarado, Marcus Maurer, Richard Gedrich, Scott B. Seibel, Michael B. Murphy, Linda Crew, Joel Goldstein, Andrea Crocker, Laura A. Vitale, Pamela A. Morani, Lawrence J. Thomas, Thomas R. Hawthorne, Tibor Keler, Diane Young, Elizabeth Crowley, Martin Kankam & Margo Heath‐Chiozzi. (2022) Anti‐KIT monoclonal antibody CDX‐0159 induces profound and durable mast cell suppression in a healthy volunteer study. Allergy 77:8, pages 2393-2403.
Crossref
Crossref
Zohreh Alyaninezhad, Ahmadreza Bekhradnia, Reza Zibandeh Gorgi, Zahra Ghanbarimasir & Morteza Fouladpour. (2022) Synthesis, characterization and biological activity of Mn(II), Co(II), Ni(II), Cu(II) and Zn(II) complexes derived from Schiff base ligand quinoxaline-2-carboxaldehyde and 4-aminoantipyrine. Journal of Molecular Structure 1262, pages 132990.
Crossref
Crossref
Timofey Lebedev, Anton Buzdin, Elmira Khabusheva, Pavel Spirin, Maria Suntsova, Maxim Sorokin, Vladimir Popenko, Petr Rubtsov & Vladimir Prassolov. (2022) Subtype of Neuroblastoma Cells with High KIT Expression Are Dependent on KIT and Its Knockdown Induces Compensatory Activation of Pro-Survival Signaling. International Journal of Molecular Sciences 23:14, pages 7724.
Crossref
Crossref
Margarida Silva, Diana Martins & Fernando Mendes. (2022) The Role of Immune Checkpoint Blockade in Acute Myeloid Leukemia. Onco 2:3, pages 164-180.
Crossref
Crossref
Shane S. Scott, Ashley N. Greenlee, Anna Matzko, Matthew Stein, Michael T. Naughton, Taborah Z. Zaramo, Ethan J. Schwendeman, Somayya J. Mohammad, Mamadou Diallo, Rohith Revan, Gabriel Shimmin, Shwetabh Tarun, Joel Ferrall, Thai H. Ho & Sakima A. Smith. (2022) Intracellular Signaling Pathways Mediating Tyrosine Kinase Inhibitor Cardiotoxicity. Heart Failure Clinics 18:3, pages 425-442.
Crossref
Crossref
Ilaria Iacobucci, Reiji Fukano, Jake D. Friske, Chunxu Qu, Laura J. Janke, Yaqi Zhao, Pradyuamna Baviskar, Emily A. Backhaus, Peter Chockley, Aman Seth, A. Douglas Laird, Anjali S. Advani & Charles G. Mullighan. (2022) G3BP2-KIT drives leukemia amenable to kinase inhibition in Ph-like ALL. Blood Advances 6:11, pages 3255-3259.
Crossref
Crossref
Prashant J. Chaudhari, Sanjaykumar B. Bari, Sanjay J. Surana, Atul A. Shirkhedkar, Chandrakant G. Bonde, Saurabh C. Khadse, Vinod G. Ugale, Akhil A. Nagar & Rameshwar S. Cheke. (2022)
Discovery and Anticancer Activity of Novel 1,3,4-Thiadiazole- and Aziridine-Based Indolin-2-ones
via In Silico
Design Followed by Supramolecular Green Synthesis
. ACS Omega 7:20, pages 17270-17294.
Crossref
Crossref
Kuan-Wei Su, Da-Liang Ou, Yu-Hsuan Fu, Hwei-Fang Tien, Hsin-An Hou & Liang-In Lin. (2021) Repurposing cabozantinib with therapeutic potential in KIT-driven t(8;21) acute myeloid leukaemias. Cancer Gene Therapy 29:5, pages 519-532.
Crossref
Crossref
Lili Yan, Zhen Zhang, Yanfen Liu, Shuyi Ren, Zhiyu Zhu, Lu Wei, Jiao Feng, Ting Duan, Xueni Sun, Tian Xie & Xinbing Sui. (2022) Anticancer Activity of Erianin: Cancer-Specific Target Prediction Based on Network Pharmacology. Frontiers in Molecular Biosciences 9.
Crossref
Crossref
Farah Hanan Fathihah Jaffar, Khairul Osman, Chua Kien Hui, Aini Farzana Zulkefli & Siti Fatimah Ibrahim. (2022) Long-Term Wi-Fi Exposure From Pre-Pubertal to Adult Age on the Spermatogonia Proliferation and Protective Effects of Edible Bird’s Nest Supplementation. Frontiers in Physiology 13.
Crossref
Crossref
Aleksandra Grela-Wojewoda, Renata Pacholczak-Madej, Agnieszka Adamczyk, Michał Korman & Mirosława Püsküllüoğlu. (2022) Cardiotoxicity Induced by Protein Kinase Inhibitors in Patients with Cancer. International Journal of Molecular Sciences 23:5, pages 2815.
Crossref
Crossref
Esteban Javier Rozen & Jason Matthew Shohet. (2021) Systematic review of the receptor tyrosine kinase superfamily in neuroblastoma pathophysiology. Cancer and Metastasis Reviews 41:1, pages 33-52.
Crossref
Crossref
Jin‐Ock Kim, Kwang‐Hyeok Kim, Eun Ji Baek, Bomi Park, Min Kyung So, Byoung Joon Ko, Han‐Jik Ko & Sang Gyu Park. (2021) A novel anti‐c‐Kit antibody–drug conjugate to treat wild‐type and activating‐mutant c‐Kit‐positive tumors. Molecular Oncology 16:6, pages 1290-1308.
Crossref
Crossref
Jacek R Wilczyński, Miłosz Wilczyński & Edyta Paradowska. (2022) Cancer Stem Cells in Ovarian Cancer—A Source of Tumor Success and a Challenging Target for Novel Therapies. International Journal of Molecular Sciences 23:5, pages 2496.
Crossref
Crossref
Sung-Gi Chi & Yosuke Minami. (2022) Emerging Targeted Therapy for Specific Genomic Abnormalities in Acute Myeloid Leukemia. International Journal of Molecular Sciences 23:4, pages 2362.
Crossref
Crossref
Anna Sobiepanek, Łukasz Kuryk, Mariangela Garofalo, Sandeep Kumar, Joanna Baran, Paulina Musolf, Frank Siebenhaar, Joachim Wilhelm Fluhr, Tomasz Kobiela, Roberto Plasenzotti, Karl Kuchler & Monika Staniszewska. (2022) The Multifaceted Roles of Mast Cells in Immune Homeostasis, Infections and Cancers. International Journal of Molecular Sciences 23:4, pages 2249.
Crossref
Crossref
Lauren E. Miller, Vivienne Au, Tara E. Mokhtari, Deborah Goss, Daniel L. Faden & Mark A. Varvares. (2022) A Contemporary Review of Molecular Therapeutic Targets for Adenoid Cystic Carcinoma. Cancers 14:4, pages 992.
Crossref
Crossref
Zheng Li, Jun Wang, Shuai-Shuai Ge, Qiao-Cheng Qiu, Jia-Hui Du, Shuang-Shuang Shan, Xiang-Dong Shen, Chao-Ling Wan, Bin-Ru Wang, De-Pei Wu, Hui-Ying Qiu & Sheng-Li Xue. (2022) Combination of Venetoclax and Midostaurin Efficiently Suppressed Relapsed t(8;21)Acute Myeloid Leukemia With Mutant KIT After Failure of Venetoclax Plus Azacitidine Treatment. Frontiers in Oncology 12.
Crossref
Crossref
David Kayes & Benjamin Blacklock. (2022) Feline Uveal Melanoma Review: Our Current Understanding and Recent Research Advances. Veterinary Sciences 9:2, pages 46.
Crossref
Crossref
Azam Rashidbaghan, Ali Mostafaie & Yaghoub Yazdani. (2022) More Related Gene Pathways to Vincristine-Induced Death Events in a Human T-Acute Lymphoblastic Leukemia Cell Line. Reports of Biochemistry and Molecular Biology 10:4, pages 554-564.
Crossref
Crossref
Ankit Srivastava, Sandhya Rai, Deepa Bisht, Manisha Sachan, Bimal Prasad Jit & Sameer Srivastava. 2022. Protein Kinase Inhibitors. Protein Kinase Inhibitors
361
391
.
Rita Bernadett Vlocskó, Sinem Apaydın, Béla Török & Marianna Török. 2022. Contemporary Chemical Approaches for Green and Sustainable Drugs. Contemporary Chemical Approaches for Green and Sustainable Drugs
457
492
.
Sarbjit Singh, Divya Utreja & Vimal Kumar. (2021) Pyrrolo[2,1-f][1,2,4]triazine: a promising fused heterocycle to target kinases in cancer therapy. Medicinal Chemistry Research 31:1, pages 1-25.
Crossref
Crossref
Shane S. Scott, Ashley N. Greenlee, Ethan J. Schwendeman, Somayya J. Mohammad, Michael T. Naughton, Anna Matzko, Mamadou Diallo, Matthew Stein, Rohith Revan, Taborah Z. Zaramo, Gabriel Shimmin, Shwetabh Tarun, Joel Ferrall, Thai H. Ho & Sakima A. Smith. 2022. Cardiovascular Signaling in Health and Disease. Cardiovascular Signaling in Health and Disease
111
173
.
Samanta Oliveira da Silva & Ellen Mayara Corrêa. 2022. The Golden Guide to Oncologic Pharmacy. The Golden Guide to Oncologic Pharmacy
121
176
.
Shelly Pathania, Olli T. Pentikäinen & Pankaj Kumar Singh. (2021) A holistic view on c-Kit in cancer: Structure, signaling, pathophysiology and its inhibitors. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1876:2, pages 188631.
Crossref
Crossref
Michael Meir, Katja Maurus, Jochen Kuper, Mohammed Hankir, Eva Wardelmann, Andreas Rosenwald, Christoph‐Thomas Germer & Armin Wiegering. (2021)
The novel
KIT
exon 11 germline mutation
K558N
is associated with gastrointestinal stromal tumor, mastocytosis, and seminoma development
. Genes, Chromosomes and Cancer 60:12, pages 827-832.
Crossref
Crossref
A.G. Nerkar. (2021) Metastatic melanomas: Treatment overview. Current Trends in Pharmacy and Pharmaceutical Chemistry 3:4, pages 50-55.
Crossref
Crossref
Morgan Brisset, Mélodie Grandin, Agnès Bernet, Patrick Mehlen & Frédéric Hollande. (2021) Dependence receptors: new targets for cancer therapy. EMBO Molecular Medicine 13:11.
Crossref
Crossref
Marius-Alexandru Beleaua, Ioan Jung, Cornelia Braicu, Doina Milutin & Simona Gurzu. (2021) Relevance of BRAF Subcellular Localization and Its Interaction with KRAS and KIT Mutations in Skin Melanoma. International Journal of Molecular Sciences 22:21, pages 11918.
Crossref
Crossref
Jatin Sharma, Vijay Kumar Bhardwaj & Rituraj Purohit. (2021) Recognition of distinct chemical molecules as inhibitors for KIT receptor mutants D816H/Y/V: A simulation approach. Journal of Molecular Liquids 339, pages 116317.
Crossref
Crossref
Xin Zhang, Wandong Wang, Yun Wang & Guan Jiang. (2021) Identification of genes and pathways leading to metastasis and poor prognosis in melanoma. Aging 13:18, pages 22474-22489.
Crossref
Crossref
Deeksha Mehtani & Niti Puri. (2021) Steering Mast Cells or Their Mediators as a Prospective Novel Therapeutic Approach for the Treatment of Hematological Malignancies. Frontiers in Oncology 11.
Crossref
Crossref
Timothy Crook, Darshana Patil, Rajnish Nagarkar, Andrew Gaya, Nicholas Plowman, Sewanti Limaye, Navin Srivastava, Dadasaheb Akolkar, Anantbhushan Ranade, Amit Bhatt, Vineet Datta, Chirantan Bose, Sachin Apurwa, Sanket Patil, Prashant Kumar, Ajay Srinivasan & Rajan Datar. (2021) Angiogenesis Inhibitors in Personalized Combination Regimens for the Treatment of Advanced Refractory Cancers. Frontiers in Molecular Medicine 1.
Crossref
Crossref
Yihebali Chi, Guangqian Ji, Jing Zhang, Haijian Tang, Yang Yang, Wei Liu, Nan Wang, Chunhui Gao, Yongkun Sun & Jinwan Wang. (2021) Efficacy and safety of anlotinib in patients with advanced malignancy: a single-center, single-arm, phase 2 trial. International Journal of Clinical Oncology 26:9, pages 1611-1618.
Crossref
Crossref
Carlos C. Smith-Díaz, Nicholas J. Magon, Judith L. McKenzie, Mark B. Hampton, Margreet C. M. Vissers & Andrew B. Das. (2021) Ascorbate Inhibits Proliferation and Promotes Myeloid Differentiation in TP53-Mutant Leukemia. Frontiers in Oncology 11.
Crossref
Crossref
M. T. Kozinova, G. A. Abalakov, D. V. Sharipova & N. L. Shimanovsky. (2021) Molecular-Genetic Basis of Gastrointestinal Stromal Tumor Personalized Therapy by Receptor Tyrosine Kinase Inhibitors (A Review). Pharmaceutical Chemistry Journal.
Crossref
Crossref
Enrico Cadoni, Pedro R. Magalhães, Rita M. Emídio, Eduarda Mendes, Jorge Vítor, Josué Carvalho, Carla Cruz, Bruno L. Victor & Alexandra Paulo. (2021) New (Iso)quinolinyl-pyridine-2,6-dicarboxamide G-Quadruplex Stabilizers. A Structure-Activity Relationship Study. Pharmaceuticals 14:7, pages 669.
Crossref
Crossref
Eunyoung Lee, Michelle Novais de Paula, Sangki Baek, Huynh Kim Khanh Ta, Minh Tan Nguyen, Taeck-Hyun Jeong, Chong Jai Kim, Yeon Jin Jang & Han Choe. (2021) Novel Bacterial Production of Two Different Bioactive Forms of Human Stem-Cell Factor. International Journal of Molecular Sciences 22:12, pages 6361.
Crossref
Crossref
Alexa M. Salsbury & Justin A. Lemkul. (2021) Cation competition and recruitment around the c-kit1 G-quadruplex using polarizable simulations. Biophysical Journal 120:11, pages 2249-2261.
Crossref
Crossref
Jacek Pietrzak, Marek Mirowski, Rafał Świechowski, Damian Wodziński, Agnieszka Wosiak, Katarzyna Michalska & Ewa Balcerczak. (2021) Importance of Altered Gene Expression of Metalloproteinases 2, 9, and 16 in Acute Myeloid Leukemia: Preliminary Study. Journal of Oncology 2021, pages 1-8.
Crossref
Crossref
Emiel P.C. van der Vorst. (2021) c-Kit inhibition: From promising cancer therapy to culprit in atherosclerosis. Atherosclerosis 324, pages 115-116.
Crossref
Crossref
Blake H. Fortes, Prashant D. Tailor & Lauren A. Dalvin. (2021) Ocular Toxicity of Targeted Anticancer Agents. Drugs 81:7, pages 771-823.
Crossref
Crossref
Daniele Fanale, Lorena Incorvaia, Giuseppe Badalamenti, Ida De Luca, Laura Algeri, Annalisa Bonasera, Lidia Rita Corsini, Chiara Brando, Antonio Russo, Juan Lucio Iovanna & Viviana Bazan. (2021) Prognostic Role of Plasma PD-1, PD-L1, pan-BTN3As and BTN3A1 in Patients Affected by Metastatic Gastrointestinal Stromal Tumors: Can Immune Checkpoints Act as a Sentinel for Short-Term Survival?. Cancers 13:9, pages 2118.
Crossref
Crossref
Elizabeth I. Buchbinder, Jason L. Weirather, Michael Manos, Brian J. Quattrochi, Lynette M. Sholl, Ryan C. Brennick, Peter Bowling, Nancy Bailey, Lisa Magarace, Patrick A. Ott, Rizwan Haq, Benjamin Izar, Anita Giobbie‐Hurder & F. Stephen Hodi. (2021) Characterization of genetics in patients with mucosal melanoma treated with immune checkpoint blockade. Cancer Medicine 10:8, pages 2627-2635.
Crossref
Crossref
Richard A. Ward, Stephen Fawell, Nicolas Floc’hVikki FlemingtonDarren McKerrecherPaul D. Smith. (2020) Challenges and Opportunities in Cancer Drug Resistance. Chemical Reviews 121:6, pages 3297-3351.
Crossref
Crossref
Asurayya Worrede, Stephen M. Douglass & Ashani T. Weeraratna. (2021) The dark side of daylight: photoaging and the tumor microenvironment in melanoma progression. Journal of Clinical Investigation 131:6.
Crossref
Crossref
Meet Patel, Adam Eckburg, Shahina Gantiwala, Zachary Hart, Joshua Dein, Katie Lam & Neelu Puri. (2021) Resistance to Molecularly Targeted Therapies in Melanoma. Cancers 13:5, pages 1115.
Crossref
Crossref
Guillermo Valdivia, Ángela Alonso-Diez, Dolores Pérez-Alenza & Laura Peña. (2021) From Conventional to Precision Therapy in Canine Mammary Cancer: A Comprehensive Review. Frontiers in Veterinary Science 8.
Crossref
Crossref
Saikat Pal & Sandip Paul. (2021)
An
in silico
investigation of the binding modes and pathway of APTO-253 on c-KIT G-quadruplex DNA
. Physical Chemistry Chemical Physics 23:5, pages 3361-3376.
Crossref
Crossref
Jinku Zhang, Jirui Sun, Sahar Bakht & Waseem Hassan. (2021) Recent Development and Future Prospects of Molecular Targeted
Therapy in Prostate Cancer. Current Molecular Pharmacology 15:1, pages 159-169.
Crossref
Crossref
Iva Brčić, Alexandra Argyropoulos & Bernadette Liegl-Atzwanger. (2021) Update on Molecular Genetics of Gastrointestinal Stromal Tumors. Diagnostics 11:2, pages 194.
Crossref
Crossref
Jin Yuan, Xiaoyang Li & Shengji Yu. (2021) Molecular targeted therapy for advanced or metastatic soft tissue sarcoma. Cancer Control 28, pages 107327482110384.
Crossref
Crossref
Christopher C. Donnell, Richard L. Walton & Marco Carrozzo. (2021) The blue palate—A case series of imatinib-related oral pigmentation and literature review. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology 131:1, pages 49-61.
Crossref
Crossref
Karen-Sue B. Carlson, Joshua Morris, Lauryn P. Cross & Sridhar Rao. 2020. Contemporary Bone Marrow Transplantation. Contemporary Bone Marrow Transplantation
1
14
.
Karen-Sue B. Carlson, Joshua Morris, Lauryn P. Cross & Sridhar Rao. 2021. Contemporary Bone Marrow Transplantation. Contemporary Bone Marrow Transplantation
29
42
.
Maryam Rahimi, Elahe Keyhani & Farkhondeh Behjati. (2020) The Relation between Exon Variations of KIT Gene and Clinical Pathological Factors of Breast Cancer. Journal of Obstetrics, Gynecology and Cancer Research 5:4, pages 137-148.
Crossref
Crossref
Ginevra Brocca, Beatrice Poncina, Alessandro Sammarco, Laura Cavicchioli & Massimo Castagnaro. (2020) KIT Somatic Mutations and Immunohistochemical Expression in Canine Oral Melanoma. Animals 10:12, pages 2370.
Crossref
Crossref
Jana Oltova, Ondrej Svoboda, Olga Machonova, Petra Svatonova, David Traver, Michal Kolar & Petr Bartunek. (2020) Zebrafish Kit ligands cooperate with erythropoietin to promote erythroid cell expansion. Blood Advances 4:23, pages 5915-5924.
Crossref
Crossref
Theresa Klümper, Henrike Bruckmueller, Tobias Diewock, Meike Kaehler, Sierk Haenisch, Christiane Pott, Oliver Bruhn & Ingolf Cascorbi. (2020) Expression differences of miR-142-5p between treatment-naïve chronic myeloid leukemia patients responding and non-responding to imatinib therapy suggest a link to oncogenic ABL2, SRI, cKIT and MCL1 signaling pathways critical for development of therapy resistance. Experimental Hematology & Oncology 9:1.
Crossref
Crossref
Shristi Bhattarai, Geetanjali Saini, Keerthi Gogineni & Ritu Aneja. (2020) Quadruple-negative breast cancer: novel implications for a new disease. Breast Cancer Research 22:1.
Crossref
Crossref
Liling Huang, Shiyu Jiang & Yuankai Shi. (2020) Tyrosine kinase inhibitors for solid tumors in the past 20 years (2001–2020). Journal of Hematology & Oncology 13:1.
Crossref
Crossref
Jorge Esteban-Villarrubia, Juan José Soto-Castillo, Javier Pozas, María San Román-Gil, Inmaculada Orejana-Martín, Javier Torres-Jiménez, Alfredo Carrato, Teresa Alonso-Gordoa & Javier Molina-Cerrillo. (2020) Tyrosine Kinase Receptors in Oncology. International Journal of Molecular Sciences 21:22, pages 8529.
Crossref
Crossref
Asadoor Amirkhani Namagerdi, Danila d’Angelo, Francesca Ciani, Carmelina Antonella Iannuzzi, Francesco Napolitano, Luigi Avallone, Michelino De Laurentiis & Antonio Giordano. (2020) Triple-Negative Breast Cancer Comparison With Canine Mammary Tumors From Light Microscopy to Molecular Pathology. Frontiers in Oncology 10.
Crossref
Crossref
Marko Kumrić, Tina Tičinović Kurir, Josip A. Borovac & Joško Božić. (2020) The Role of Natural Killer (NK) Cells in Acute Coronary Syndrome: A Comprehensive Review. Biomolecules 10:11, pages 1514.
Crossref
Crossref
Béla Tóth, Norbert Kiss, Judit Hársing, Sarolta Kárpáti, Judit Csomor, Csaba Bödör, József Tímár & Erzsébet Rásó. (2020) Frequent KIT mutations in skin lesions of patients with BRAF wild-type Langerhans cell histiocytosis. Virchows Archiv 477:5, pages 749-753.
Crossref
Crossref
Sanjay K. Srikakulam, Tomas Bastys & Olga V. Kalinina. (2020)
A shift of dynamic equilibrium between the
KIT
active and inactive states causes drug resistance
. Proteins: Structure, Function, and Bioinformatics 88:11, pages 1434-1446.
Crossref
Crossref
Emily J. Hanan, Jun Liang, Xiaojing Wang, Robert A. Blake, Nicole Blaquiere & Steven T. Staben. (2020) Monomeric Targeted Protein Degraders. Journal of Medicinal Chemistry 63:20, pages 11330-11361.
Crossref
Crossref
Tal Tilayov, Tal Hingaly, Yariv Greenshpan, Shira Cohen, Barak Akabayov, Roi Gazit & Niv Papo. (2020) Engineering Stem Cell Factor Ligands with Different c-Kit Agonistic Potencies. Molecules 25:20, pages 4850.
Crossref
Crossref
Paulina Sobierajska, Anna Serwotka-Suszczak, Damian Szymanski, Krzysztof Marycz & Rafal J. Wiglusz. (2020) Nanohydroxyapatite-Mediated Imatinib Delivery for Specific Anticancer Applications. Molecules 25:20, pages 4602.
Crossref
Crossref
Zhichao Tian, Xiaohui Niu & Weitao Yao. (2020) Receptor Tyrosine Kinases in Osteosarcoma Treatment: Which Is the Key Target?. Frontiers in Oncology 10.
Crossref
Crossref
Jarmila Nahálková. (2020) Linking TPPII to the protein interaction and signalling networks. Computational Biology and Chemistry 87, pages 107291.
Crossref
Crossref
Zhengyun Zou, Qiuxiang Ou, Yu Ren, Qing Lv, Lanqun Qin, Lianjun Zhao, Shu Su, Xue Wu, Hua Bao, Ao Wang, Dongqin Zhu, Xiaonan Wang, Yang W. Shao & Baorui Liu. (2020) Distinct genomic traits of acral and mucosal melanomas revealed by targeted mutational profiling. Pigment Cell & Melanoma Research 33:4, pages 601-611.
Crossref
Crossref
Kirsten McAulayEmily A. Hoyt, Morgan ThomasMarianne Schimpl, Michael S. Bodnarchuk, Hilary J. Lewis, Derek BarrattDeepa Bhavsar, David M. RobinsonMichael J. DeeryDerek J. OggGonçalo J. L. Bernardes, Richard A. Ward, Michael J. Waring & Jason G. Kettle. (2020) Alkynyl Benzoxazines and Dihydroquinazolines as Cysteine Targeting Covalent Warheads and Their Application in Identification of Selective Irreversible Kinase Inhibitors. Journal of the American Chemical Society 142:23, pages 10358-10372.
Crossref
Crossref
Sathyen A. Prabhu, Omar Moussa, Wilson H. MillerJr.Jr. & Sonia V. del Rincón. (2020) The MNK1/2-eIF4E Axis as a Potential Therapeutic Target in Melanoma. International Journal of Molecular Sciences 21:11, pages 4055.
Crossref
Crossref
Alexa M. Salsbury, Tanner J. Dean & Justin A. Lemkul. (2020)
Polarizable Molecular Dynamics Simulations of Two
c-kit
Oncogene Promoter G-Quadruplexes: Effect of Primary and Secondary Structure on Loop and Ion Sampling
. Journal of Chemical Theory and Computation 16:5, pages 3430-3444.
Crossref
Crossref
Ching-Liang Chu, Yi-Pang Lee, Cheng-Yoong Pang, Huei-Ru Lin, Chang-Shan Chen & Ren-In You. (2020) Tyrosine kinase inhibitors modulate dendritic cell activity via confining c-Kit signaling and tryptophan metabolism. International Immunopharmacology 82, pages 106357.
Crossref
Crossref
Abdulaziz B. Hamid & Ruben C. Petreaca. (2020) Secondary Resistant Mutations to Small Molecule Inhibitors in Cancer Cells. Cancers 12:4, pages 927.
Crossref
Crossref
Carlos Anerillas, Kotb Abdelmohsen & Myriam Gorospe. (2020) Regulation of senescence traits by MAPKs. GeroScience 42:2, pages 397-408.
Crossref
Crossref
Ala’a S. Shraim, Abdelrahim Hunaiti, Abdalla Awidi, Walhan Alshaer, Nidaa A. Ababneh, Bashaer Abu-Irmaileh, Fadwa Odeh & Said Ismail. (2019) Developing and Characterization of Chemically Modified RNA Aptamers for Targeting Wild Type and Mutated c-KIT Receptor Tyrosine Kinases. Journal of Medicinal Chemistry 63:5, pages 2209-2228.
Crossref
Crossref
Lior Zimmerman, Ori Zelichov, Arie Aizenmann, Zohar Barbash, Michael Vidne & Gabi Tarcic. (2020) A Novel System for Functional Determination of Variants of Uncertain Significance using Deep Convolutional Neural Networks. Scientific Reports 10:1.
Crossref
Crossref
Celeste Lorusso, Simona De Summa, Rosamaria Pinto, Katia Danza & Stefania Tommasi. (2020) miRNAs as Key Players in the Management of Cutaneous Melanoma. Cells 9:2, pages 415.
Crossref
Crossref
James Sun, Michael J. Carr & Nikhil I. Khushalani. (2020) Principles of Targeted Therapy for Melanoma. Surgical Clinics of North America 100:1, pages 175-188.
Crossref
Crossref
Cheolhee Kim & Eunae Kim. (2020) Rational Drug Design Approach of Receptor Tyrosine Kinase Type III Inhibitors. Current Medicinal Chemistry 26:42, pages 7623-7640.
Crossref
Crossref
Soma Ghosh, Ilaria Marrocco & Yosef Yarden. 2020. Receptor Tyrosine Kinases. Receptor Tyrosine Kinases
1
57
.
V. Doma, T. Barbai, M.-A. Beleaua, I. Kovalszky, E. Rásó & József Tímár. (2019) KIT Mutation Incidence and Pattern of Melanoma in Central Europe. Pathology & Oncology Research 26:1, pages 17-22.
Crossref
Crossref
Anisha Viswanathan, Aliyu Musa, Akshaya Murugesan, João Vale, Carlos Afonso, Saravanan Konda Mani, Olli Yli-Harja, Nuno Candeias & Meenakshisundaram Kandhavelu. (2019) Battling Glioblastoma: A Novel Tyrosine Kinase Inhibitor with Multi-Dimensional Anti-Tumor Effect. Cells 8:12, pages 1624.
Crossref
Crossref
Sanjay de Mel, Susan Swee-Shan Hue, Anand D. Jeyasekharan, Wee-Joo Chng & Siok-Bian Ng. (2019) Molecular pathogenic pathways in extranodal NK/T cell lymphoma. Journal of Hematology & Oncology 12:1.
Crossref
Crossref
Yara Abdou, Ankita KapoorLamya Hamad & Marc S. Ernstoff. (2019) Combination of pembrolizumab and imatinib in a patient with double KIT mutant melanoma. Medicine 98:44, pages e17769.
Crossref
Crossref
Mohd Mughees, Mohd Samim, Yadhu Sharma & Saima Wajid. (2019)
Identification of protein targets and the mechanism of the cytotoxic action of
Ipomoea turpethum
extract loaded nanoparticles against breast cancer cells
. Journal of Materials Chemistry B 7:39, pages 6048-6063.
Crossref
Crossref
Mariana M. Fachi, Fernanda S. Tonin, Leticia P. Leonart, Inajara Rotta, Fernando Fernandez‐Llimos & Roberto Pontarolo. (2019) Haematological adverse events associated with tyrosine kinase inhibitors in chronic myeloid leukaemia: A network meta‐analysis. British Journal of Clinical Pharmacology 85:10, pages 2280-2291.
Crossref
Crossref
Chung Chew Hwang, Masaya Igase, Masaru Okuda, Matt Coffey, Shunsuke Noguchi & Takuya Mizuno. (2019) Reovirus changes the expression of anti-apoptotic and proapoptotic proteins with the c-kit downregulation in canine mast cell tumor cell lines. Biochemical and Biophysical Research Communications 517:2, pages 233-237.
Crossref
Crossref
M. E. El-Houseini, A. Ismail, A. A. Abdelaal, A. H. El-Habashy, Z. F. Abdallah, M. Z. Mohamed, M. El-Hadidi, W. C. S. Cho, H. Ahmed & T. A. Al-Shafie. (2019) Role of TGF-β1 and C-Kit Mutations in the Development of Hepatocellular Carcinoma in Hepatitis C Virus-Infected Patients: in vitro Study. Biochemistry (Moscow) 84:8, pages 941-953.
Crossref
Crossref
J.G. Rushton, M. Korb, S. Kummer, U. Reichart, A. Fuchs-Baumgartinger, A. Tichy & B. Nell. (2019) Protein expression of KIT, BRAF, GNA11, GNAQ and RASSF1 in feline diffuse iris melanomas. The Veterinary Journal 249, pages 33-40.
Crossref
Crossref
Weina Zhang, Ying Lu, Tao Zhen, Xinjie Chen, Ming Zhang, Ping Liu, Xiangqin Weng, Bing Chen & Yueying Wang. (2019) Homoharringtonine synergy with oridonin in treatment of t(8; 21) acute myeloid leukemia. Frontiers of Medicine 13:3, pages 388-397.
Crossref
Crossref
Xuesong Liu, Beilei Wang, Cheng Chen, Ziping Qi, Fengming Zou, Junjie Wang, Chen Hu, Aoli Wang, Juan Ge, Qingwang Liu, Kailin Yu, Zhenquan Hu, Zongru Jiang, Wei Wang, Li Wang, Wenchao Wang, Tao Ren, Mingfeng Bai, Qingsong Liu & Jing Liu. (2019)
Discovery of (
E
)-
N
1
-(3-Fluorophenyl)-
N
3
-(3-(2-(pyridin-2-yl)vinyl)-1
H
-indazol-6-yl)malonamide (CHMFL-KIT-033) as a Novel c-KIT T670I Mutant Selective Kinase Inhibitor for Gastrointestinal Stromal Tumors (GISTs)
. Journal of Medicinal Chemistry 62:10, pages 5006-5024.
Crossref
Crossref
Marilina García-Aranda & Maximino Redondo. (2019) Targeting Protein Kinases to Enhance the Response to anti-PD-1/PD-L1 Immunotherapy. International Journal of Molecular Sciences 20:9, pages 2296.
Crossref
Crossref
Asuncion Martinez-Anton, Delphine Gras, Arnaud Bourdin, Patrice Dubreuil & Pascal Chanez. (2019) KIT as a therapeutic target for non-oncological diseases. Pharmacology & Therapeutics 197, pages 11-37.
Crossref
Crossref
Chen Lu, Hongli Lu, Xu Huang, Shaohua Liu, Jingyu Zang, Yujia Li, Jie Chen & Wenxie Xu. (2019) Colonic Transit Disorder Mediated by Downregulation of Interstitial Cells of Cajal/Anoctamin-1 in Dextran Sodium Sulfate-induced Colitis Mice. Journal of Neurogastroenterology and Motility 25:2, pages 316-331.
Crossref
Crossref
Marilina García-Aranda & Maximino Redondo. (2019) Targeting Receptor Kinases in Colorectal Cancer. Cancers 11:4, pages 433.
Crossref
Crossref
Paola Savoia, Paolo Fava, Filippo Casoni & Ottavio Cremona. (2019) Targeting the ERK Signaling Pathway in Melanoma. International Journal of Molecular Sciences 20:6, pages 1483.
Crossref
Crossref
Guofeng Chen, Anqi Liu, Yihan Xu, Li Gao, Mengmeng Jiang, Yan Li, Na Lv, Lei Zhou, Lili Wang, Li Yu & Yonghui Li. (2019)
The RUNX1–ETO fusion protein
trans
‐activates
c‐KIT
expression by recruiting histone acetyltransferase P300 on its promoter
. The FEBS Journal 286:5, pages 901-912.
Crossref
Crossref
Alexa M. Salsbury & Justin A. Lemkul. (2018)
Molecular Dynamics Simulations of the
c-kit1
Promoter G-Quadruplex: Importance of Electronic Polarization on Stability and Cooperative Ion Binding
. The Journal of Physical Chemistry B 123:1, pages 148-159.
Crossref
Crossref
Dimple R. Bhatia, Sushmita Rath & Sudeep Gupta. 2019. Unravelling Cancer Signaling Pathways: A Multidisciplinary Approach. Unravelling Cancer Signaling Pathways: A Multidisciplinary Approach
539
583
.
Jana Oltova, Ondrej Svoboda & Petr Bartunek. (2018) Hematopoietic Cytokine Gene Duplication in Zebrafish Erythroid and Myeloid Lineages. Frontiers in Cell and Developmental Biology 6.
Crossref
Crossref
Shaocong Wu & Liwu Fu. (2018) Tyrosine kinase inhibitors enhanced the efficacy of conventional chemotherapeutic agent in multidrug resistant cancer cells. Molecular Cancer 17:1.
Crossref
Crossref
Kyriakos P. Papadopoulos, Eytan Ben-Ami, Amita Patnaik, Denise Trone, Jianke Li & George D. Demetri. (2018) Safety and tolerability of quizartinib, a FLT3 inhibitor, in advanced solid tumors: a phase 1 dose-escalation trial. BMC Cancer 18:1.
Crossref
Crossref
Mario Buono, Marie-Laëtitia Thézénas, Alessandro Ceroni, Roman Fischer & Claus Nerlov. (2018) Bi-directional signaling by membrane-bound KitL induces proliferation and coordinates thymic endothelial cell and thymocyte expansion. Nature Communications 9:1.
Crossref
Crossref
Haohai Jiang, Weiwei Shao, Yuanjin Wang, Ronghui Xu, Linsen Zhou & Xiangming Mu. (2018) Molecular mechanism of D816X mutation-induced c-Kit activation and -mediated inhibitor resistance in gastrointestinal stromal tumor. Journal of Molecular Graphics and Modelling 84, pages 189-196.
Crossref
Crossref
Jay Amin, Bo Xu, Shervin Badkhshan, Terrance T. Creighton, Daniel Abbotoy, Christine Murekeyisoni, Kristopher M. Attwood, Thomas Schwaab, Craig Hendler, Michael Petroziello, Charles L. Roche & Eric C. Kauffman. (2018) Identification and Validation of Radiographic Enhancement for Reliable Differentiation of CD117(+) Benign Renal Oncocytoma and Chromophobe Renal Cell Carcinoma. Clinical Cancer Research 24:16, pages 3898-3907.
Crossref
Crossref
Lawrence L'Italien, Olivia Orozco, Tinya Abrams, Lisa Cantagallo, Anu Connor, Jayesh Desai, Hilmar Ebersbach, Hans Gelderblom, Keith Hoffmaster, Emma Lees, Heiko Maacke, Siew Schleyer, Darko Skegro & Si Tuen Lee-Hoeflich. (2018) Mechanistic Insights of an Immunological Adverse Event Induced by an Anti-KIT Antibody Drug Conjugate and Mitigation Strategies. Clinical Cancer Research 24:14, pages 3465-3474.
Crossref
Crossref
Kyunghee Choi. (2018) ETS transcription factor ETV2/ER71/Etsrp in haematopoietic regeneration. Current Opinion in Hematology 25:4, pages 253-258.
Crossref
Crossref
Sanjay de Mel, Gwyneth Soon, Yingting Mok, Tae-Hoon Chung, Anand Jeyasekharan, Wee-Joo Chng & Siok-Bian Ng. (2018) The Genomics and Molecular Biology of Natural Killer/T-Cell Lymphoma: Opportunities for Translation. International Journal of Molecular Sciences 19:7, pages 1931.
Crossref
Crossref
Brittni Foster, Danish Zaidi, Tyler Young, Mary Mobley & Bethany Kerr. (2018) CD117/c-kit in Cancer Stem Cell-Mediated Progression and Therapeutic Resistance. Biomedicines 6:1, pages 31.
Crossref
Crossref
Chilaluck C. Konkankit, Sierra C. Marker, Kevin M. Knopf & Justin J. Wilson. (2018) Anticancer activity of complexes of the third row transition metals, rhenium, osmium, and iridium. Dalton Transactions 47:30, pages 9934-9974.
Crossref
Crossref
Görkem Eskiizmir, Yasemin Baskın & Kerim Yapıcı. 2018. Fullerens, Graphenes and Nanotubes. Fullerens, Graphenes and Nanotubes
331
374
.
Michela Lupia & Ugo Cavallaro. (2017) Ovarian cancer stem cells: still an elusive entity?. Molecular Cancer 16:1.
Crossref
Crossref
Helena Kaitsiotou, Marina Keul, Julia Hardick, Thomas Mühlenberg, Julia Ketzer, Christiane Ehrt, Jasmin Krüll, Federico Medda, Oliver Koch, Fabrizio Giordanetto, Sebastian Bauer & Daniel Rauh. (2017) Inhibitors to Overcome Secondary Mutations in the Stem Cell Factor Receptor KIT. Journal of Medicinal Chemistry 60:21, pages 8801-8815.
Crossref
Crossref
Yi He, Huizhi Zeng, Yang Yu, Jiashu Zhang, Xingping Duan, Qi Liu & Bo Yang. (2017) Resveratrol improves smooth muscle carcinogenesis in the progression of chronic prostatitis via the downregulation of c-kit/SCF by activating Sirt1. Biomedicine & Pharmacotherapy 95, pages 161-166.
Crossref
Crossref
Martha L. Slattery, Jennifer S. Herrick, Lila E. Mullany, Wade S. Samowitz, John R. Sevens, Lori Sakoda & Roger K. Wolff. (2017) The co‐regulatory networks of tumor suppressor genes, oncogenes, and miRNAs in colorectal cancer. Genes, Chromosomes and Cancer 56:11, pages 769-787.
Crossref
Crossref
Yan‐yan Chu, He‐juan Cheng, Zhen‐hua Tian, Jian‐chun Zhao, Gang Li, Yang‐yang Chu, Chang‐jun Sun & Wen‐bao Li. (2017) Rational drug design of indazole‐based diarylurea derivatives as anticancer agents. Chemical Biology & Drug Design 90:4, pages 609-617.
Crossref
Crossref
Marília I. Figueira, Henrique J. Cardoso, Sara Correia, Cláudio J. Maia & Sílvia Socorro. (2017) The stem cell factor (SCF)/c-KIT system in carcinogenesis of reproductive tissues: What does the hormonal regulation tell us?. Cancer Letters 405, pages 10-21.
Crossref
Crossref
Yi He, Huizhi Zeng, Yang Yu, Jiashu Zhang, Xiaona Zeng, Fengtao Gong, Xingping Duan, Qi Liu & Bo Yang. (2017) Resveratrol Improved the Progression of Chronic Prostatitis via the Downregulation of c-kit/SCF by Activating Sirt1. Journal of Agricultural and Food Chemistry 65:28, pages 5668-5673.
Crossref
Crossref
Agnese GugliandoloThangavelu Soundara RajanDomenico SciontiFrancesca DiomedePlacido BramantiEmanuela MazzonOriana Trubiani. (2017)
Reprogramming of Oncogene Expression in Gingival Mesenchymal Stem Cells Following Long-Term Culture
In Vitro
. Cellular Reprogramming 19:3, pages 159-170.
Crossref
Crossref